Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Assets: 2019-2024

Historic Assets for Avidity Biosciences (RNA) over the last 6 years, with Dec 2024 value amounting to $1.6 billion.

  • Avidity Biosciences' Assets rose 30.07% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 30.07%. This contributed to the annual value of $1.6 billion for FY2024, which is 148.81% up from last year.
  • Avidity Biosciences' Assets amounted to $1.6 billion in FY2024, which was up 148.81% from $628.6 million recorded in FY2023.
  • Avidity Biosciences' 5-year Assets high stood at $1.6 billion for FY2024, and its period low was $333.9 million during FY2020.
  • Its 3-year average for Assets is $943.8 million, with a median of $638.8 million in 2022.
  • In the last 5 years, Avidity Biosciences' Assets skyrocketed by 244.56% in 2020 and then dropped by 1.60% in 2023.
  • Over the past 5 years, Avidity Biosciences' Assets (Yearly) stood at $333.9 million in 2020, then climbed by 28.06% to $427.6 million in 2021, then skyrocketed by 49.40% to $638.8 million in 2022, then decreased by 1.60% to $628.6 million in 2023, then surged by 148.81% to $1.6 billion in 2024.